In addition to the approval of novel medications for alcohol use disorders, the past several years have been marked by an emphasis on development, standardization, and dissemination of new behavioral therapies, including computer-based interventions.
There is increasing evidence and support for medications for alcohol use disorders to be used in regular clinical practice, and not to be limited to specialty substance abuse settings. Here, special considerations for pharmacological management.
The topics in this Special Report provide a broad picture of the issues psychiatrists face as they take a clear-eyed look at the opportunities and challenges in the emerging health care system.
Although most major organizations recognize the importance of collaboration, the challenge for psychiatry is how to best integrate different aspects of psychiatric and primary care. Help here.
Psychiatrists are particularly susceptible to burnout because of the nature of their work and the populations they serve. Combat strategies here.
This article reviews the many forms of fee agreement and notes the important factors to consider as well as questions to ask to properly assess and vet what may be best for one’s practice.
Everything you need to know about the MOC process.
An overview of Behavioral Neurology and Neuropsychiatry, a medical specialty committed to better understanding links between neuroscience and behavior and to the care of individuals with neurologically based behavioral disturbances.
The term “CTE” was introduced recently to describe progressive neuropathological changes and diffuse neuropsychiatric symptoms associated with a history of TBI. Here, a clinical overview of TBI and CTE.
Psychiatric comorbidity in epilepsy represents not only a matter of intellectual interest but also an important variable that affects prognosis in terms of morbidity and mortality.